References
Aguirre-Ezkauriatza EJ, Aguilar-Yáñez JM, Ramírez-Medrano A, Alvarez MM. 2010. Production of probiotic biomass (Lactobacillus casei ) in goat milk whey: Comparison of batch, continuous and fed-batch cultures. Bioresource Technology.101:2837–44.
Babi DK, Cruz MS, Gani R. 2016. Chapter 2 - Fundamentals of Process Intensification: A Process Systems Engineering View. Process Intensification in Chemical Engineering. X, 336 p. DOI 10.1007/978-3-319-28392-0_2
Berenjian A, Mahanama R, Talbot A, Regtop H, Kavanagh J, Dehghani F. 2014. Designing of an Intensification Process for Biosynthesis and Recovery of Menaquinone-7 Appl Biochem Biotechnol. 172:1347–1357
Callewaert R, De Vuyst L. 2000. Bacteriocin production withLactobacillus amylovorus DCE 471 is improved and stabilized by fed-batch fermentation. Applied and Environmental Microbiology. 66(2):606–13.
Campos IB, Herd M, Moffitt KL, Lu YJ, Darrieux M, Malley R, Leite LCC, Gonçalves VM. 2017. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine. Vaccine. 35: 1306-1315.
Carvalho SM, Kuipers OP, Neves AR. 2013. Environmental and nutritional factors that affect growth and metabolism of the pneumococcal serotype 2 strain D39 and its nonencapsulated derivative strain R6. Plos One. 8(3):1-15.
Chang HN, Yoo IK, Kim BS. 1994. High density cell culture by membrane-based cell recycle. Biotech. Adv. 12:467-87.
ClinicalTrials.gov [Internet]. Bethesda, MD, USA: U.S. National Library of Medicine from National Institutes of Health (NIH); 2014 [update 2014 May 6]. Available from: https://clinicaltrials.gov/ct2/show/NCT01537185.
Ding S, Tan T. 2006. L-lactic acid production by Lactobacillus casei fermentation using different fed-batch feeding strategies. Process Biochemistry. 41:1451–4.
Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH. 2015. Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev. 28 (3): 871-899.
Gogola-Kolling VMR, Zanardo RT, Carmo TS, Zampoli ND, Figueiredo DB, Gonçalves VM. 2014. Improved capsular polysaccharide production byStreptococcus pneumoniae serotype 14 using continuous cultivation. Biochem Eng J. 91:16–22.
Gonçalves VM, Dias WO, Campos IB, Liberman C, Sbrogio-Almeida ME, Silva EP, Cardoso Jr. CP, Alderson M, Robertson G, Maisonneuve JF, Tate A, Anderson P, Malley M, Fratelli F, Leite LCC. 2014. Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability. Vaccine. 32:1113–1120.
Gonçalves VM, Zangirolami TC, Giordano RLC, Raw I, Tanizaki MM, Giordano RC. 2002. Optimization of medium and cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 23F. Appl Microbiol Biotechnol. 59:713–7.
John RP, Nampoothiri KM, Pandey A. 2007. Fermentative production of lactic acid from biomass: an overview on process developments and future perspectives. Appl Microbiol Biotechnol. 74:524–534.
Kwon S, Yoo IK, Lee WG, Chang HN, Chang YK. 2001. High-Rate Continuous Production of lactic acid by Lactobacillus rhamnosus in a two-stage membrane cell-recycle bioreactor. Biotechnology and Bioengineering. 73(1):25-34.
Leal MM, Pereira DSG, Jessouroun E, Couto MAPG, Pereira N. 2011. Investigation of cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 14. Electronic Journal of Biotechnology. 14(5):1-7.
Liberman C, Takagi M, Cabrera-Crespo J, Sbrogio-Almeida ME, Dias WO, Leite LCC, Gonçalves VM. 2008. Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium. J Ind Microbiol Biotechnol. 35(11):1441-1445.
Liberman C, Kolling D, Sari RS, Takagi M, Cabrera-Crespo J, Sbrogio Almeida ME, Pradella JGC, Leite LCC, Gonçalves VM. 2011. Use of soy peptones for Streptococcus pneumoniae cultivation for vaccine production. In: Maxwell JE, editor. Soybeans: Cultivation, Uses and Nutrition. New York. New Science Publishers Inc.; Cap. 17, p. 415-26.
Lu YJ, Yadav P, Clements JD, Forte S, Srivastava A, Thompson CM, Seid R, Look J, Alderson M, Tate A, Maisonneuve JF, Robertson G, Anderson P, Malley R. 2010a. Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine. Clinical and Vaccine Immunology. 17(6):1005–1012.
Lu YJ, Leite L, Gonçalves VM, Dias Wde O, Liberman C, Fratelli F, Alderson M, Tate A, Maisonneuve JF, Robertson G, Graca R, Sayeed S, Thompson CM, Anderson P, Malley R. 2010b. GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis. Vaccine. 28(47):7468-7475.
Lu F, Li C, Wang Z, Zhao W, Chu J, Zhuang Y, Zhang S. 2016. High efficiency cell-recycle continuous sodium gluconate production byAspergillus niger using on-line physiological parameters association analysis to regulate feed rate rationally. Bioresour Technol. 220:433-41.
Lutze P, Gani R, Woodley JM. 2010. Process intensification: A perspective on process synthesis. Chemical Engineering and Processing. 49:547–558
Min-tian G, Koide M, Gotou R, Takanashi H, Hirata M, Hano T. 2005. Development of a continuous electrodialysis fermentation system for production of lactic acid by Lactobacillus rhamnosus . Process Biochemistry 40:1033-1036
Ohleyer E, Blanch HW, Wilke CR. 1985. Continuous production of lactic acid in a cell recycle reactor. Applied Biochemistry and Biotechnology 11:317-32.
Parente E, Ricciardi A, Addario G. 1994. Influence of pH on growth and bacteriocin production by Lactococcus lactis subsp. lactis140NWC during batch fermentation. Appl Microbiol Biotechnol.41:388-94.
Pollard AJ, Perrett KP, Beverley PC. 2009. Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines. Nature Reviews Immunology 9:213-20.
Taniguchi M, Kotani N, Kobayashi T. 1987. High-concentration cultivation of lactic acid bacteria in fermentor with cross-flow filtration. J. Ferment. Technol. 65(2):179-84.
Tapia F, Vázquez-Ramírez D, Genzel Y, Reichl U. 2016. Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Appl Microbiol Biotechnol. 100:2121–2132
Tejayadi S, Cheryan M. 1995. Lactic acid from cheese whey permeate. Productivity and economics of a continuous membrane bioreactor. Applied Microbiology and Biotechnology. 43, 2:242–248.
Wee YJ, Kim JN, Yun JS, Ryu HW. 2004. Utilization of sugar molasses for economical L(+)-lactic acid production by batch fermentation ofEnterococcus faecalis . Enzyme and Microbial Technology. 35:568–73.
Wee YJ, Ryu HW. 2009. Lactic acid production by Lactobacillus sp. RKY2 in a cell-recycle continuous fermentation using lignocellulosic hydrolyzates as inexpensive raw materials. Bioresource Technology. 100:4262–70.
Weinberger DM, Malley R, Lipsitch M. 2011. Serotype replacement in disease following pneumococcal vaccination: A discussion of the evidence Lancet. 378(9807): 1962–1973.
Xu GQ, Chu J, Wang YH, Zhuang YP, Zhang SL, Peng HQ. 2006. Development of a continuous cell-recycle fermentation system for production of lactic acid by Lactobacillus paracasei . Process Biochemistry. 41:2458–63.
Yesilkaya H, Spissu F, Carvalho SM, Terra VS, Homer KA, Benisty R, Porat N, Neves AR, Andrew PW. 2009. Pyruvate formate lyase is required for pneumococcal fermentative metabolism and virulence. Infection and Immunity. 77(12):5418–5427.